EBV and malignant lymphoma with special emphasis on pyothorax-associated lymphoma.
Aozasa
K
K
Department of Pathology (C3), Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Kanno
H
H
Miwa
H
H
Tomita
Y
Y
D016207:Cytokines / Q000276:immunology; D016724:Empyema, Pleural / Q000150:complications* / Q000276:immunology / Q000473:pathology / Q000821:virology*; D019309:Epstein-Barr Virus Nuclear Antigens / Q000235:genetics / Q000276:immunology; D016158:Genes, p53 / Q000235:genetics; D006680:HLA Antigens / Q000235:genetics; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D019288:Herpesvirus 8, Human / Q000502:physiology; D006689:Hodgkin Disease / Q000276:immunology / Q000473:pathology / Q000821:virology; D006801:Humans; D008223:Lymphoma / Q000150:complications* / Q000276:immunology / Q000473:pathology / Q000821:virology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D016207:Cytokines; C438197:EBNA4 antigen; D019309:Epstein-Barr Virus Nuclear Antigens; D006680:HLA Antigens